Artículos por temáticas

Office-based endoscopic botulinum toxin injection in laryngeal movement disorders.

Kaderbay A, Righini CA, Castellanos PF, Atallah I.

Eur Ann Otorhinolaryngol Head Neck Dis. 2018 Apr 13. pii: S1879-7296(18)30030-9. doi: 10.1016/j.anorl.2018.01.007. [Epub ahead of print]

Newer advances in lesional surgery for movement disorders.

Sankhe M, Churi O.

Neurol India. 2018 Mar-Apr;66(Supplement):S113-S121. doi: 10.4103/0028-3886.226463.

Male and female opinions about orthotic devices of the lower limb: A multicentre, observational study in patients with central neurological movement disorders.

Swinnen E, Lefeber N, Werbrouck A, Gesthuizen Y, Ceulemans L, Christiaens S, De Wael L, Buyl R, Ilsbroukx S, Van Nieuwenhoven J, Michielsen M, Lafosse C, Kerckhofs E.

NeuroRehabilitation. 2018;42(1):121-130. doi: 10.3233/NRE-172214.

Autoimmune and paraneoplastic movement disorders: An update.

Baizabal-Carvallo JF, Jankovic J.

J Neurol Sci. 2018 Feb 15;385:175-184. doi: 10.1016/j.jns.2017.12.035. Epub 2017 Dec 30. Review.

Focused ultrasound subthalamotomy in patients with asymmetric Parkinson's disease: a pilot study.

Martínez-Fernández R, Rodríguez-Rojas R, Del Álamo M, Hernández-Fernández F, Pineda-Pardo JA, Dileone M, Alonso-Frech F, Foffani G, Obeso I, Gasca-Salas C, de Luis-Pastor E, Vela L, Obeso JA.

Lancet Neurol. 2018 Jan;17(1):54-63. doi: 10.1016/S1474-4422(17)30403-9. Epub 2017 Dec 5.

Why orthotic devices could be of help in the management of Movement Disorders in the young.

Garavaglia L, Pagliano E, Baranello G, Pittaccio S.

J Neuroeng Rehabil. 2018 Dec 14;15(1):118. doi: 10.1186/s12984-018-0466-8. Review.

Imaging Transplantation in Movement Disorders.

de Natale ER, Wilson H, Pagano G, Politis M.

Int Rev Neurobiol. 2018;143:213-263. doi: 10.1016/bs.irn.2018.10.002. Epub 2018 Nov 3.

Botulinum neurotoxin for the treatment of movement disorders.

Kopanidis P, Das C.

Aust J Gen Pract. 2018 Sep;47(9):598-601.

Intraoperative stereotactic MRI for deep brain stimulation electrode planning in patients with movement disorders.

Jakobs M, Krasniqi E, Kloß M, Neumann JO, Campos B, Unterberg AW, Kiening KL.

World Neurosurg. 2018 Aug 7. pii: S1878-8750(18)31750-9. doi: 10.1016/j.wneu.2018.07.270. [Epub ahead of print]

DAT-SPECT imaging in cases of drug-induced parkinsonism in a specialty movement disorders practice.

Yomtoob J, Koloms K, Bega D.

Parkinsonism Relat Disord. 2018 May 5. pii: S1353-8020(18)30221-9. doi: 10.1016/j.parkreldis.2018.04.037. [Epub ahead of print]

[Sleep-related movement disorders].

Haba-Rubio J, Siclari F, Heinzer R.

Rev Med Suisse. 2018 Apr 25;14(604):883-887. French.

Recessive mutations in VPS13D cause childhood-onset movement disorders.

Gauthier J, Meijer IA, Lessel D, Mencacci NE, Krainc D, Hempel M, Tsiakas K, Prokisch H, Rossignol E, Helm MH, Rodan LH, Karamchandani J, Carecchio M, Lubbe SJ, Telegrafi A, Henderson LB, Lorenzo K, W

Ann Neurol. 2018 Mar 8. doi: 10.1002/ana.25204. [Epub ahead of print]

Rechargeable Internal Pulse Generators as Initial Neurostimulators for Deep Brain Stimulation in Patients With Movement Disorders.

Jakobs M, Kloß M, Unterberg A, Kiening K.

Neuromodulation. 2018 Jan 8. doi: 10.1111/ner.12748. [Epub ahead of print]

Performance of the Movement Disorders Society criteria for prodromal Parkinson's disease: A population-based 10-year study.

Mahlknecht P, Gasperi A, Djamshidian A, Kiechl S, Stockner H, Willeit P, Willeit J, Rungger G, Poewe W, Seppi K.

Mov Disord. 2018 Feb 13. doi: 10.1002/mds.27281. [Epub ahead of print]

Parkinson disease: Blood transcriptomics for Parkinson disease?

Chen-Plotkin AS.

Nat Rev Neurol. 2018 Jan;14(1):5-6. doi: 10.1038/nrneurol.2017.166. Epub 2017 Dec 1. No abstract available.